NDC 13811-012 - FerraPlus 90
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13811-012
- Package NDCs from labels
- 13811-012-90
- Manufacturer
- Trigen Laboratories, LLC
- Effective date
- 2022-01-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FerraPlus 90 - Trigen Laboratories, LLC | Trigen Laboratories, LLC | 2022-01-20 | DIETARY SUPPLEMENT |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13811-012-90 | EA - Each | 13811-012 | a783a3e5-f46a-4238-8291-3af367f94cd7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Curewell Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | RMT HEALTH LLC | 55903043-2a1d-0525-e063-6394a90ae182 | 2026-07-01 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | Aarkish Pharmaceuticals NJ Inc. | faca8f3e-d9eb-44c5-93ab-f59ed1c0f56f | 2026-07-01 | Warnings | F05Q2T2JA0 |
| ENEMEEZ | DOCUSATE SODIUM | Quest Products, LLC | 0b06445d-0839-497e-bdff-e0fe224a7738 | 2026-06-30 | Warnings | F05Q2T2JA0 |
| ENEMEEZ Plus | DOCUSATE SODIUM AND BENZOCAINE | Quest Products, LLC | 1670ca59-7275-4ac6-bef4-674a7b24c7b3 | 2026-06-30 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | c1f588d0-4600-4b97-b2d3-2c08ac351e07 | 2026-06-30 | Warnings | F05Q2T2JA0 |
| Bambusa Stannum | BAMBUSA STANNUM | Uriel Pharmacy Inc. | a0d4d0ac-e2d2-4381-8f93-e41719521859 | 2026-06-30 | Warnings | ETJ7Z6XBU4 |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eab581-bc48-f9f0-e063-6394a90a4b93 | 2026-06-25 | IY9XDZ35W2 | |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | be7cab51-ce7e-465d-95db-083e69288cfd | 2026-06-25 | Warnings | F05Q2T2JA0 |
| SET 4TE HOMO | ADEPS SUILLUS, BRYONIA (ALBA), CALCAREA PHOSPHORICA, CHOLINUM, DNA, DOPAMINE (HYDROCHLORIDE), FERRUM PHOSPHORICUM, FOLIC ACID, INSULINUM (HUMAN), LEPTIN, MAGNESIA MURIATICA, L-METHIONINE, METHYLCOBALAMIN, PROTEUS (VULGARIS), RHUS TOX, RIBOFLAVINUM, RUTA GRAVEOLENS, SACCHARUM OFFICINALE, THIOSINAMINUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | e7b8d75b-f2bc-4013-91e7-bf5bbec11a90 | 2026-06-25 | Warnings | 935E97BOY8 |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 2968PHW8QP 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 2968PHW8QP 1Q73Q2JULR | |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54fdf3cf-41df-af7d-e063-6294a90ab1e6 | 2026-06-24 | IY9XDZ35W2 | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 2968PHW8QP 1Q73Q2JULR | |
| Minovia Mini | MINOVIA MINI | Oncora Pharma, LLC | 297673c1-23db-47b5-8cfb-aaecc0790838 | 2026-06-24 | Warnings, Adverse reactions | 935E97BOY8 PQ6CK8PD0R P6YC3EG204 |
| MCAS Support | APIS MELLIFICA, ANTIMONIUM CRUDUM, ASCORBICUM ACIDUM, BOVISTA, CARBOLICUM ACIDUM, CHAMOMILLA, CORTISONE ACETICUM, GINKGO BILOBA, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, NATRUM MURIATICUM, QUERCETIN, RHUS TOX, SCUTELLARIA LATERIFLORA, STOMACH (SUIS), URTICA URENS | Deseret Biologicals, Inc. | af3d5f8f-6f24-4045-8730-c776ff54bcc4 | 2026-06-24 | Warnings | PQ6CK8PD0R |
| Blood Collection System | CP2D/AS-3 TRIPLE WITH SAMPLING SYSTEM | GVS TM INC | 54e8cfd2-f91b-8381-e063-6394a90a3f77 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54e9a497-7a94-44c9-e063-6294a90a84da | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb0462-cd00-4467-e063-6394a90aa371 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb3c81-5cc8-03c4-e063-6294a90a2065 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54ebb700-3bcf-d0e3-e063-6394a90a57c8 | 2026-06-23 | IY9XDZ35W2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.